Rockove S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.

Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group. Nitti VW, et al. J Urol. 2017 Feb;197(2S):S216-S223. doi: 10.1016/j.juro.2016.10.109. Epub 2016 Dec 22. J Urol. 2017. PMID: 28012773 Clinical Trial.

OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.

Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group. Nitti VW, et al. J Urol. 2013 Jun;189(6):2186-93. doi: 10.1016/j.juro.2012.12.022. Epub 2012 Dec 14. J Urol. 2013. PMID: 23246476 Clinical Trial.

Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.

Burney TL, Rockove S, Eiseman JL, Jacobs SC, Kyprianou N. Burney TL, et al. Among authors: rockove s. Prostate. 1994 Oct;25(4):177-88. doi: 10.1002/pros.2990250403. Prostate. 1994. PMID: 8084835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters